1 | ongoing | 6,910 |
2 | on-going | 268 |
3 | early-phase | 96 |
4 | event-based | 63 |
5 | ed-based | 39 |
6 | nih-funded | 27 |
7 | health-sponsored | 26 |
8 | postapproval | 20 |
9 | noncommercial | 18 |
10 | health-funded | 16 |
11 | institution-based | 14 |
12 | asteroid | 8 |
13 | pan-african | 8 |
14 | eight-site | 7 |
15 | icu-based | 7 |
16 | post-authorization | 7 |
17 | uncompleted | 7 |
18 | industry-driven | 6 |
19 | mpac | 6 |
20 | nimh-funded | 6 |
21 | preapproval | 6 |
22 | fast-2 | 5 |
23 | unfinished | 5 |
24 | multiarmed | 4 |
25 | preregistered | 4 |
26 | uncharacteristic | 4 |
27 | 8-site | 3 |
28 | all-female | 3 |
29 | effort-dependent | 3 |
30 | exploratory-descriptive | 3 |
31 | fmri-naming | 3 |
32 | homeotherms | 3 |
33 | indication-seeking | 3 |
34 | physician-expressed | 3 |
35 | postlaunch | 3 |
36 | premating | 3 |
37 | published/unpublished | 3 |
38 | all-japan | 2 |
39 | comparison-controlled | 2 |
40 | cue-invariant | 2 |
41 | cyp450-mediated | 2 |
42 | delusionality | 2 |
43 | enterprising | 2 |
44 | klempner | 2 |
45 | lap07 | 2 |
46 | mishel | 2 |
47 | nonconfounded | 2 |
48 | pulse-alone | 2 |
49 | signal-hit | 2 |
50 | 'osheroff | 1 |
51 | //in | 1 |
52 | 11-member | 1 |
53 | 3,6-connected | 1 |
54 | 4,091 | 1 |
55 | 85-centre | 1 |
56 | 96,346 | 1 |
57 | all-too | 1 |
58 | almost-7-year | 1 |
59 | amr-free | 1 |
60 | angiographic-based | 1 |
61 | aroa-deleted | 1 |
62 | b*44:02/44:27 | 1 |
63 | care.three | 1 |
64 | century-old | 1 |
65 | congruent-oddball | 1 |
66 | dadverse | 1 |
67 | deferasirox.five | 1 |
68 | drb1*14:01/14:54 | 1 |
69 | ego-dystonic | 1 |
70 | ehr-facilitated | 1 |
71 | ethics-committee-approved | 1 |
72 | exposure-discordant | 1 |
73 | extends-the | 1 |
74 | famous-infamous | 1 |
75 | fomenting | 1 |
76 | heart-spirit | 1 |
77 | ilsi-hesi | 1 |
78 | immunotherapy-focused | 1 |
79 | lbp.no | 1 |
80 | marginal.four | 1 |
81 | methyprednisolne | 1 |
82 | mid-/late | 1 |
83 | no-aid | 1 |
84 | notms | 1 |
85 | nutrition-norfolk | 1 |
86 | onr | 1 |
87 | open-cluster | 1 |
88 | outcome.twelve | 1 |
89 | participants-a | 1 |
90 | placebo.four | 1 |
91 | preserved.most | 1 |
92 | recommended.further | 1 |
93 | sas-only | 1 |
94 | self-irrelevant | 1 |
95 | signal-miss | 1 |
96 | summer/spring | 1 |
97 | truth-falsehood | 1 |
98 | un-commissioned | 1 |
1 | 'osheroff | 1 |
2 | //in | 1 |
3 | 11-member | 1 |
4 | 3,6-connected | 1 |
5 | 4,091 | 1 |
6 | 8-site | 3 |
7 | 85-centre | 1 |
8 | 96,346 | 1 |
9 | all-female | 3 |
10 | all-japan | 2 |
11 | all-too | 1 |
12 | almost-7-year | 1 |
13 | amr-free | 1 |
14 | angiographic-based | 1 |
15 | aroa-deleted | 1 |
16 | asteroid | 8 |
17 | b*44:02/44:27 | 1 |
18 | care.three | 1 |
19 | century-old | 1 |
20 | comparison-controlled | 2 |
21 | congruent-oddball | 1 |
22 | cue-invariant | 2 |
23 | cyp450-mediated | 2 |
24 | dadverse | 1 |
25 | deferasirox.five | 1 |
26 | delusionality | 2 |
27 | drb1*14:01/14:54 | 1 |
28 | early-phase | 96 |
29 | ed-based | 39 |
30 | effort-dependent | 3 |
31 | ego-dystonic | 1 |
32 | ehr-facilitated | 1 |
33 | eight-site | 7 |
34 | enterprising | 2 |
35 | ethics-committee-approved | 1 |
36 | event-based | 63 |
37 | exploratory-descriptive | 3 |
38 | exposure-discordant | 1 |
39 | extends-the | 1 |
40 | famous-infamous | 1 |
41 | fast-2 | 5 |
42 | fmri-naming | 3 |
43 | fomenting | 1 |
44 | health-funded | 16 |
45 | health-sponsored | 26 |
46 | heart-spirit | 1 |
47 | homeotherms | 3 |
48 | icu-based | 7 |
49 | ilsi-hesi | 1 |
50 | immunotherapy-focused | 1 |
51 | indication-seeking | 3 |
52 | industry-driven | 6 |
53 | institution-based | 14 |
54 | klempner | 2 |
55 | lap07 | 2 |
56 | lbp.no | 1 |
57 | marginal.four | 1 |
58 | methyprednisolne | 1 |
59 | mid-/late | 1 |
60 | mishel | 2 |
61 | mpac | 6 |
62 | multiarmed | 4 |
63 | nih-funded | 27 |
64 | nimh-funded | 6 |
65 | no-aid | 1 |
66 | noncommercial | 18 |
67 | nonconfounded | 2 |
68 | notms | 1 |
69 | nutrition-norfolk | 1 |
70 | on-going | 268 |
71 | ongoing | 6,910 |
72 | onr | 1 |
73 | open-cluster | 1 |
74 | outcome.twelve | 1 |
75 | pan-african | 8 |
76 | participants-a | 1 |
77 | physician-expressed | 3 |
78 | placebo.four | 1 |
79 | post-authorization | 7 |
80 | postapproval | 20 |
81 | postlaunch | 3 |
82 | preapproval | 6 |
83 | premating | 3 |
84 | preregistered | 4 |
85 | preserved.most | 1 |
86 | published/unpublished | 3 |
87 | pulse-alone | 2 |
88 | recommended.further | 1 |
89 | sas-only | 1 |
90 | self-irrelevant | 1 |
91 | signal-hit | 2 |
92 | signal-miss | 1 |
93 | summer/spring | 1 |
94 | truth-falsehood | 1 |
95 | un-commissioned | 1 |
96 | uncharacteristic | 4 |
97 | uncompleted | 7 |
98 | unfinished | 5 |
1 | 4,091 | 1 |
2 | fast-2 | 5 |
3 | drb1*14:01/14:54 | 1 |
4 | 96,346 | 1 |
5 | lap07 | 2 |
6 | b*44:02/44:27 | 1 |
7 | participants-a | 1 |
8 | mpac | 6 |
9 | ego-dystonic | 1 |
10 | uncharacteristic | 4 |
11 | nih-funded | 27 |
12 | nimh-funded | 6 |
13 | health-funded | 16 |
14 | nonconfounded | 2 |
15 | published/unpublished | 3 |
16 | unfinished | 5 |
17 | comparison-controlled | 2 |
18 | multiarmed | 4 |
19 | un-commissioned | 1 |
20 | preregistered | 4 |
21 | health-sponsored | 26 |
22 | angiographic-based | 1 |
23 | ed-based | 39 |
24 | institution-based | 14 |
25 | event-based | 63 |
26 | icu-based | 7 |
27 | physician-expressed | 3 |
28 | immunotherapy-focused | 1 |
29 | cyp450-mediated | 2 |
30 | ehr-facilitated | 1 |
31 | 3,6-connected | 1 |
32 | aroa-deleted | 1 |
33 | uncompleted | 7 |
34 | ethics-committee-approved | 1 |
35 | no-aid | 1 |
36 | asteroid | 8 |
37 | century-old | 1 |
38 | truth-falsehood | 1 |
39 | amr-free | 1 |
40 | care.three | 1 |
41 | extends-the | 1 |
42 | all-female | 3 |
43 | methyprednisolne | 1 |
44 | pulse-alone | 2 |
45 | 85-centre | 1 |
46 | early-phase | 96 |
47 | dadverse | 1 |
48 | mid-/late | 1 |
49 | 8-site | 3 |
50 | eight-site | 7 |
51 | deferasirox.five | 1 |
52 | exploratory-descriptive | 3 |
53 | outcome.twelve | 1 |
54 | 'osheroff | 1 |
55 | indication-seeking | 3 |
56 | fmri-naming | 3 |
57 | on-going | 268 |
58 | ongoing | 6,910 |
59 | summer/spring | 1 |
60 | enterprising | 2 |
61 | premating | 3 |
62 | fomenting | 1 |
63 | postlaunch | 3 |
64 | ilsi-hesi | 1 |
65 | nutrition-norfolk | 1 |
66 | noncommercial | 18 |
67 | preapproval | 6 |
68 | postapproval | 20 |
69 | mishel | 2 |
70 | congruent-oddball | 1 |
71 | pan-african | 8 |
72 | all-japan | 2 |
73 | industry-driven | 6 |
74 | //in | 1 |
75 | post-authorization | 7 |
76 | lbp.no | 1 |
77 | all-too | 1 |
78 | almost-7-year | 1 |
79 | 11-member | 1 |
80 | recommended.further | 1 |
81 | klempner | 2 |
82 | open-cluster | 1 |
83 | onr | 1 |
84 | marginal.four | 1 |
85 | placebo.four | 1 |
86 | homeotherms | 3 |
87 | notms | 1 |
88 | signal-miss | 1 |
89 | famous-infamous | 1 |
90 | signal-hit | 2 |
91 | heart-spirit | 1 |
92 | exposure-discordant | 1 |
93 | cue-invariant | 2 |
94 | self-irrelevant | 1 |
95 | effort-dependent | 3 |
96 | preserved.most | 1 |
97 | sas-only | 1 |
98 | delusionality | 2 |